References
- Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005;45:1243-1248. https://doi.org/10.1016/j.jacc.2005.01.015
- Nishimura M, Uzu T, Fujii T, et al. Cardiovascular complications in patients with primary aldosteronism. Am J Kidney Dis 1999;33:261-266. https://doi.org/10.1016/S0272-6386(99)70298-2
- Brown NJ. Aldosterone and vascular inflammation. Hypertension 2008;51:161-167. https://doi.org/10.1161/HYPERTENSIONAHA.107.095489
- Nakajima Y, Yamada M, Taguchi R, et al. Cardiovascular complications of patients with aldosteronism associated with autonomous cortisol secretion. J Clin Endocrinol Metab 2011;96:2512-2518. https://doi.org/10.1210/jc.2010-2743
- Rogers KM, Bonar CA, Estrella JL, Yang S. Inhibitory effect of glucocorticoid on coronary artery endothelial function. Am J Physiol Heart Circ Physiol 2002;283:H1922-H1928.
Cited by
- Aldosteronism with mild hypokalemia presenting as life-threatening ventricular arrhythmias : A case report vol.97, pp.50, 2018, https://doi.org/10.1097/md.0000000000013608
- Machine learning based models for prediction of subtype diagnosis of primary aldosteronism using blood test vol.11, pp.1, 2021, https://doi.org/10.1038/s41598-021-88712-8